ロード中...
Safety and efficacy of fimasartan with essential hypertension patients in real world clinical practice: data from a post marketing surveillance in Korea
The safety and efficacy of fimasartan have been evaluated through post-marketing surveillance in real world clinical practice. The multi-center, prospective, open-label and non-interventional study. A total of 3,945 patients (3,729 patients for safety assessment and 3,473 patients for efficacy asses...
保存先:
| 出版年: | Transl Clin Pharmacol |
|---|---|
| 主要な著者: | , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Korean Society for Clinical Pharmacology and Therapeutics
2018
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6989236/ https://ncbi.nlm.nih.gov/pubmed/32055561 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12793/tcp.2018.26.3.118 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|